Phar Vision Advisers, LLC Bioventus Inc. Transaction History
Phar Vision Advisers, LLC
- $178 Billion
- Q3 2025
A detailed history of Phar Vision Advisers, LLC transactions in Bioventus Inc. stock. As of the latest transaction made, Phar Vision Advisers, LLC holds 15,302 shares of BVS stock, worth $112,469. This represents 0.06% of its overall portfolio holdings.
Number of Shares
15,302
Previous 10,072
51.93%
Holding current value
$112,469
Previous $66.7 Million
53.53%
% of portfolio
0.06%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding BVS
# of Institutions
145Shares Held
50.1MCall Options Held
42.5KPut Options Held
100K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$95.7 Million28.43% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$51 Million18.87% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.81MShares$42.7 Million1.58% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$21.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$17.4 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $453M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...